UCB
€204.30Change from previous close: +1.49%Absolute change: +€3.00
At a glance
- Revenue growth
- +25.83%
- 2025 vs 2024
- Net income growth
- +46.29%
- 2025 vs 2024
- Net margin
- 20.1%
- 2024: 17.3%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,270 | 4,254 | 3,487 | 3,361 | 2,791 | 2,663 | 2,519 | — | 2,855 | 2,999 |
| Cost of revenue | 959 | 1,068 | 922 | 901 | 851 | 905 | 802 | — | 845 | 749 |
| Gross profit | 3,311 | 3,186 | 2,565 | 2,460 | 1,940 | 1,758 | 1,717 | — | 2,010 | 2,250 |
| Selling, general and administrative | 1,368 | 1,471 | 1,278 | 1,281 | 1,066 | 967 | 857 | — | 845 | 850 |
| Research and development | 913 | 962 | 860 | 992 | 789 | 871 | 759 | — | 798 | 876 |
| Operating income | 1,423 | 1,293 | 694 | 522 | 326 | 165 | 413 | — | 468 | 631 |
| EBIT | 1,423 | 1,293 | 694 | 522 | 326 | 165 | 413 | — | 468 | 631 |
| EBITDA | 1,735 | 1,607 | 1,007 | 845 | 644 | 541 | 728 | — | 731 | 748 |
| Interest expense | 80.0 | 35.0 | 124 | 82.0 | 79.0 | 80.0 | 64.0 | — | 48.0 | 46.0 |
| Pre-tax income | 1,304 | 1,229 | 593 | 917 | 246 | 40.0 | 401 | — | 481 | 582 |
| Income tax | 193 | 146 | 118 | 60.0 | 38.0 | 8.0 | 90.0 | — | 82.0 | 94.0 |
| Net income | 1,111 | 1,083 | 475 | 857 | 208 | 32.0 | 311 | — | 399 | 487 |
| Net income to common shareholders | 1,111 | 1,083 | 475 | 857 | 208 | 32.0 | 311 | — | 399 | 487 |
| Basic EPS | 5.83 | 5.69 | 2.50 | 4.51 | 1.10 | 0.17 | 1.64 | — | 2.10 | 2.58 |
| Diluted EPS | 5.73 | 5.59 | 2.44 | 4.43 | 1.06 | 0.16 | 1.60 | — | 2.05 | 2.51 |
| Average shares (basic) | 191 | 190 | 190 | 190 | 190 | 190 | 189 | — | 190 | 189 |
| Average shares (diluted) | 194 | 194 | 194 | 194 | 195 | 196 | 195 | — | 195 | 194 |